Investor Relations

Financial News

Date	Title
05/10/22	Clinical Value of MRIdian® MRI-Guided Radiation Therapy in the Treatment of Ultracentral/Central Lung Tumors Presented at ESTRO 2022 PDF Version
05/06/22	MRIdian Clinical and Research Experience Featured in Nearly 40 Abstracts at ESTRO 2022, the Leading European Radiation Oncology Meeting PDF Version
05/05/22	ViewRay Announces First Quarter 2022 Results PDF Version
05/05/22	ViewRay Named “Best Overall MedTech Company” in 2022 MedTech Breakthrough Awards Program
05/03/22	UCI Health Adopts ViewRay® MRIdian® MRI-Guided Radiation Therapy System PDF Version
04/21/22	ViewRay Announces Conference Call for First Quarter 2022 Financial Results to be Held After Market on May 5, 2022 PDF Version
03/15/22	University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy PDF Version
03/10/22	ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on March 16, 2022 PDF Version
03/10/22	First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer PDF Version
03/09/22	ViewRay Enters into Cooperation Agreement with Hudson Executive Capital PDF Version
03/03/22	Acibadem Group Purchases Second MRIdian® System for Acibadem Altunizade Hospital in Istanbul PDF Version
02/24/22	ViewRay Announces Fourth Quarter and Full Year 2021 Results PDF Version
02/15/22	Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer PDF Version
02/10/22	ViewRay Announces Conference Call for Fourth Quarter and Full Year 2021 Financial Results to be Held After Market on February 24, 2022 PDF Version
02/10/22	ViewRay® to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference PDF Version
02/09/22	University Hospital Halle (Saale) Selects ViewRay's MRIdian® System to Broaden Advanced Radiation Therapy Treatment Services PDF Version
01/25/22	ViewRay® to Participate in the B. Riley Securities Oncology Conference PDF Version
01/10/22	ViewRay Announces Preliminary Fourth Quarter and Full Year 2021 Results PDF Version

Stock Quote

(Common Stock)
Exchange	(US Dollar)
Price
Change (%)
Volume

Data as of 04/14/22 11:59 pm EDT

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Website: www.amstock.com
Email: info@amstock.com

In Need of Customer Support? Contact

Language Select